NLRP3 and melanoma: Interestingly, our results show that IL-1β is not decreased in the TME of melanoma-bearing Nlrp3-/- animals (data not shown), indicating that NLRP3 ablation may promote tumor regression and MDSC subset re-programming via an IL-1β-independent mechanism.